Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 1539-1545, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaked, A.
Right arrow Articles by Lucey, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaked, A.
Right arrow Articles by Lucey, M. R.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Clinical Immunology
Right arrow Arnold O. Beckman Conference
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 1997;43:1539-1545.)
© 1997 American Association for Clinical Chemistry, Inc.

Articles

Assessment of liver function: pre- and peritransplant evaluation

Abraham Shakeda, Fredrick A. Nunes1, Kim M. Olthoff and Michael R. Lucey1

Departments of Surgery and
1 Medicine, University of Pennsylvania, Philadelphia, PA.
a Address correspondence to this author at: Hospital of the University of Pennsylvania, Department of Surgery, 3400 Spruce St., Philadelphia, PA 19104. Fax 215-662-2244; email shaked{at}mail.med.upenn.edu

Liver transplantation has been demonstrated to be a successful therapeutic modality for patients with end-stage liver disease. The high rate of survival for an otherwise terminal condition has resulted in significant expansion of the indications and diseases treated by this procedure, and is hampered only by the limited numbers of organs available for transplantation. Efforts in clinical and laboratory medicine should be directed to identify candidates who would benefit most from this procedure, to provide better means for accurate assessment of liver reserve and the appropriate timing for transplantation, to identify quality liver grafts that would have the potential to tolerate cold preservation and reperfusion injury, and to assist in accurate monitoring of graft function immediately after transplantation. The aim of this manuscript is to describe the existing pathways for clinical and laboratory assessment of pretransplant residual liver function, the donor liver graft, and immediate posttransplantation function.


Key Words: indexing terms: liver transplatation • end-stage liver disease • reperfusion injury • liver reserve






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.